LianBio (LIANY)
OTCMKTS · Delayed Price · Currency is USD
0.0950
0.00 (0.00%)
At close: Dec 31, 2025
LianBio Market Cap
LianBio has a market cap or net worth of $10.28 million as of January 2, 2026. Its market cap has decreased by -67.25% in one year.
Market Cap
10.28M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since November 1, 2021, LianBio's market cap has decreased from 1.44B to 10.28M, a decrease of -99.29%. That is a compound annual growth rate of -69.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 10.28M | -64.15% |
| Dec 31, 2024 | 28.66M | -94.07% |
| Dec 29, 2023 | 483.04M | 171.83% |
| Dec 30, 2022 | 177.70M | -73.10% |
| Dec 31, 2021 | 660.59M | -54.19% |
| Nov 1, 2021 | 1.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 723.19M |
| Elite Pharmaceuticals | 503.55M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 352.68M |
| CytoDyn | 325.20M |
| Silence Therapeutics | 298.05M |
| Nika Pharmaceuticals | 291.10M |